Brind.

Monopar Therapeutics shares began trading on the Nasdaq stock exchange.

4 reports, 3 independent Updated Jul 24

Gone quiet

Reports: 4
Developments: 1
Repetition: 75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Monopar Therapeutics shares began trading on the Nasdaq stock exchange.

Who's involved

What this event is mainly about

Monopar Therapeutics Nasdaq

Keep exploring

The entities involved

Monopar Therapeutics
biopharmaceutical company

Nothing else this week.
Nasdaq
American fully electronic stock exchange
- Maya is pursuing a domestic listing and has filed financial statements with the SEC, with foreign partners potentially eyeing a Nasdaq listing.03:46
- Nasdaq decline triggered a selloff across the chip sector.03:25

Related events

Coverage

Newest first; wire copies grouped

Jul 24tickerreport.com
Jul 24dailypolitical.comMonopar Therapeutics (NASDAQ:MNPR) Price Target Raised to $125.00
Jul 17themarketsdaily.com
Jun 25tickerreport.com